Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19
J Med Virol
.
2023 Jun;95(6):e28836.
doi: 10.1002/jmv.28836.
Authors
Guangting Zeng
1
,
Linlin Wang
2
,
Jianqiang Li
3
,
Zanling Zhang
3
Affiliations
1
Department of Pharmacy, The First People's Hospital of Chenzhou, Xiangnan University, Chenzhou, China.
2
Department of Pharmacy, Cancer Center(Xiamen), Fudan University, Xiamen, China.
3
Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China.
PMID:
37247396
DOI:
10.1002/jmv.28836
No abstract available
Publication types
Letter
Comment
MeSH terms
Antiviral Agents / therapeutic use
COVID-19 Drug Treatment
COVID-19*
Humans
Ritonavir* / therapeutic use
Substances
azvudine
nirmatrelvir
Ritonavir
Antiviral Agents